Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 83
Filter
1.
Why is rickets resurgent in the USA?
Rowe, P M.
Lancet ; 357(9262): 1100, 2001 Apr 07.
Article in English | MEDLINE | ID: mdl-11297967

Subject(s)
Rickets/epidemiology , Rickets/etiology , Breast Feeding/adverse effects , Child , Dietary Supplements , Female , Humans , Incidence , Male , United States/epidemiology , Vitamin D/administration & dosage , Vitamin D Deficiency/epidemiology , Vitamin D Deficiency/etiology
2.
Chronic Lyme disease: the debate goes on.
Rowe, P M.
Lancet ; 355(9213): 1436, 2000 Apr 22.
Article in English | MEDLINE | ID: mdl-10791535

Subject(s)
Autoimmune Diseases/immunology , Lyme Disease/complications , Anti-Bacterial Agents/therapeutic use , Autoimmune Diseases/drug therapy , Chronic Disease , Europe , Humans , Lyme Disease/drug therapy , Syndrome , United States
3.
Glycoscience moves from the laboratory to the clinic.
Rowe, P M.
Lancet ; 354(9176): 402, 1999 Jul 31.
Article in English | MEDLINE | ID: mdl-10437881

Subject(s)
1-Deoxynojirimycin/therapeutic use , Anti-Bacterial Agents/therapeutic use , Anti-HIV Agents/therapeutic use , Antineoplastic Agents/therapeutic use , Antiviral Agents/therapeutic use , Enzyme Inhibitors/therapeutic use , Glucosamine/analogs & derivatives , Swainsonine/therapeutic use , 1-Deoxynojirimycin/chemistry , Anti-Bacterial Agents/chemistry , Anti-HIV Agents/chemistry , Antineoplastic Agents/chemistry , Antiviral Agents/chemistry , Enzyme Inhibitors/chemistry , Glucosamine/chemistry , Glucosamine/therapeutic use , HIV-1/drug effects , Humans , Structure-Activity Relationship , Swainsonine/chemistry
4.
What is all the hullabaloo about endostatin?
Rowe, P M.
Lancet ; 353(9154): 732, 1999 Feb 27.
Article in English | MEDLINE | ID: mdl-10073527

Subject(s)
Antineoplastic Agents/therapeutic use , Collagen/therapeutic use , Neoplasms, Experimental/drug therapy , Peptide Fragments/therapeutic use , Animals , Endostatins , Humans , Mice , Reproducibility of Results
5.
Visible Human Project pays back investment.
Rowe, P M.
Lancet ; 353(9146): 46, 1999 Jan 02.
Article in English | MEDLINE | ID: mdl-10023961

Subject(s)
Anatomy, Cross-Sectional , Computers , National Library of Medicine (U.S.)/economics , Female , Humans , Magnetic Resonance Imaging , Male , Patient Simulation , Tomography , United States
6.
Septic shock: finding the way through the maze.
Rowe, P M.
Lancet ; 354(9195): 2058, 1999 Dec 11.
Article in English | MEDLINE | ID: mdl-10636381

Subject(s)
Shock, Septic/etiology , Gram-Negative Bacteria/immunology , Humans , Lipopolysaccharides/antagonists & inhibitors , Lipopolysaccharides/immunology , Shock, Septic/diagnosis , Shock, Septic/immunology
7.
Treating type 1 diabetes by regulating autoimmunity.
Rowe, P M.
Lancet ; 352(9132): 966, 1998 Sep 19.
Article in English | MEDLINE | ID: mdl-9752830

Subject(s)
Autoimmunity , Diabetes Mellitus, Type 1/immunology , Diabetes Mellitus, Type 1/genetics , Diabetes Mellitus, Type 1/prevention & control , Humans
8.
Unravelling the complexities of environmental effects on breast-cancer risk.
Rowe, P M.
Lancet ; 351(9118): 1791, 1998 Jun 13.
Article in English | MEDLINE | ID: mdl-9635962

Subject(s)
Breast Neoplasms/etiology , Environmental Exposure/adverse effects , Female , Humans , Male , Risk Factors
9.
Photodynamic therapy begins to shine.
Rowe, P M.
Lancet ; 351(9114): 1496, 1998 May 16.
Article in English | MEDLINE | ID: mdl-9605816

Subject(s)
Photochemotherapy , Esophageal Neoplasms/drug therapy , Hematoporphyrin Photoradiation , Humans , Lung Neoplasms/drug therapy , Palliative Care , Skin Neoplasms/drug therapy
10.
The ups and downs of T-cell recovery in HIV-1 disease.
Rowe, P M.
Lancet ; 350(9079): 720, 1997 Sep 06.
Article in English | MEDLINE | ID: mdl-9291915

Subject(s)
Anti-HIV Agents/pharmacology , CD4-Positive T-Lymphocytes/drug effects , HIV Infections/immunology , Anti-HIV Agents/therapeutic use , CD4 Lymphocyte Count/drug effects , Humans
11.
Breaking the mother-to-child transmission of HIV-1.
Rowe, P M.
Lancet ; 350(9080): 788, 1997 Sep 13.
Article in English | MEDLINE | ID: mdl-9298009

Subject(s)
HIV Infections/transmission , HIV-1 , Infectious Disease Transmission, Vertical/prevention & control , Pregnancy Complications, Infectious/drug therapy , Anti-HIV Agents/therapeutic use , Female , HIV Infections/prevention & control , Humans , Infant, Newborn , Pregnancy , Zidovudine/therapeutic use
12.
Getting the vaccine strategy right in HIV-1 disease.
Rowe, P M.
Lancet ; 349(9063): 1454, 1997 May 17.
Article in English | MEDLINE | ID: mdl-9164329

Subject(s)
AIDS Vaccines , HIV-1 , AIDS Vaccines/immunology , HIV-1/immunology , Humans , Vaccination
13.
Patterns of AIDS-related malignancies discussed at US meeting.
Rowe, P M.
Lancet ; 349(9062): 1372, 1997 May 10.
Article in English | MEDLINE | ID: mdl-9149710

Subject(s)
HIV Infections/complications , Lymphoma, Non-Hodgkin/virology , Sarcoma, Kaposi/virology , Uterine Cervical Neoplasms/virology , Female , Humans , Risk Factors
14.
Nonoxynol-9 fails to protect against HIV-1.
Rowe, P M.
Lancet ; 349(9058): 1074, 1997 Apr 12.
Article in English | MEDLINE | ID: mdl-9107254

Subject(s)
HIV Infections/prevention & control , HIV-1 , Nonoxynol/therapeutic use , Female , HIV Infections/transmission , Humans , Sex Work , Sexually Transmitted Diseases/prevention & control
15.
Multidrug-resistance gene employed to advantage.
Rowe, P M.
Lancet ; 349(9055): 858, 1997 Mar 22.
Article in English | MEDLINE | ID: mdl-9121273

Subject(s)
ATP Binding Cassette Transporter, Subfamily B, Member 1/genetics , Antineoplastic Agents/therapeutic use , Drug Resistance, Multiple , Bone Marrow Transplantation , Gene Expression , Hematopoietic Stem Cell Transplantation , Humans , Transfection
16.
Changing the risky behaviour of politicians.
Rowe, P M.
Lancet ; 349(9051): 520, 1997 Feb 22.
Article in English | MEDLINE | ID: mdl-9048787

Subject(s)
HIV Infections/prevention & control , Politics , Public Health , Public Policy , Risk-Taking , Acquired Immunodeficiency Syndrome/prevention & control , Humans , Needle-Exchange Programs , United States
17.
Starve the tumour, save the patient.
Rowe, P M.
Lancet ; 349(9045): 108, 1997 Jan 11.
Article in English | MEDLINE | ID: mdl-9011734

Subject(s)
Antineoplastic Agents/pharmacology , Neoplasms, Experimental/drug therapy , Peptide Fragments/pharmacology , Plasminogen/pharmacology , Angiostatins , Animals , Humans , Neoplasms, Experimental/pathology , Neoplasms, Experimental/secondary , Neovascularization, Pathologic
18.
US expert panel reaffirms benefit of perinatal zidovudine.
Rowe, P M.
Lancet ; 349(9047): 258, 1997 Jan 25.
Article in English | MEDLINE | ID: mdl-9014924

Subject(s)
Acquired Immunodeficiency Syndrome/drug therapy , Anti-HIV Agents/therapeutic use , HIV-1 , Pregnancy Complications, Infectious/drug therapy , Zidovudine/therapeutic use , Animals , Anti-HIV Agents/adverse effects , Female , Humans , Infectious Disease Transmission, Vertical/prevention & control , Mice , Neoplasms, Experimental/chemically induced , Pregnancy , Zidovudine/adverse effects
19.
Signalling an end to transplant rejection?
Rowe, P M.
Lancet ; 350(9090): 1526, 1997 Nov 22.
Article in English | MEDLINE | ID: mdl-9417481

Subject(s)
Graft Rejection/immunology , T-Lymphocytes/immunology , Animals , Antigens, CD/immunology , Graft Rejection/prevention & control , Humans , Kidney Transplantation/immunology
20.
Ribozymes enter clinical trials for HIV-1 treatment.
Rowe, P M.
Lancet ; 348(9037): 1302, 1996 Nov 09.
Article in English | MEDLINE | ID: mdl-8909386

Subject(s)
HIV Infections/therapy , HIV-1 , RNA, Catalytic/therapeutic use , Animals , Humans , Rabbits
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL